Cargando…
Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation
High-risk Human papillomaviruses (HPVs) types are associated with more than 90% of premalignant and malignant squamous lesions of the uterine cervix. The E6 oncoprotein of high-risk HPVs is a key determinant in cell transformation because it induces the degradation of the host pro-apoptotic tumor su...
Autores principales: | Li, Siying, Hong, Xiaoling, Wei, Zhentong, Xie, Min, Li, Wanying, Liu, Guanchen, Guo, Haoran, Yang, Jiaxin, Wei, Wei, Zhang, Songling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842930/ https://www.ncbi.nlm.nih.gov/pubmed/31749782 http://dx.doi.org/10.3389/fmicb.2019.02483 |
Ejemplares similares
-
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
por: Martinez-Zapien, Denise, et al.
Publicado: (2016) -
The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6
por: Zanier, Katia, et al.
Publicado: (2014) -
Docosahexaenoic acid induces the degradation of HPV E6/E7 oncoproteins by activating the ubiquitin–proteasome system
por: Jing, K, et al.
Publicado: (2014) -
HPV E6, E6AP and cervical cancer
por: Beaudenon, Sylvie, et al.
Publicado: (2008) -
In silico analyzing the molecular interactions of plant-derived inhibitors against E6AP, p53, and c-Myc binding sites of HPV type 16 E6 oncoprotein
por: Nabati, Farzan, et al.
Publicado: (2020)